SG11201707892YA - Methods and compositions for treating inflammatory and immunological disorders - Google Patents
Methods and compositions for treating inflammatory and immunological disordersInfo
- Publication number
- SG11201707892YA SG11201707892YA SG11201707892YA SG11201707892YA SG11201707892YA SG 11201707892Y A SG11201707892Y A SG 11201707892YA SG 11201707892Y A SG11201707892Y A SG 11201707892YA SG 11201707892Y A SG11201707892Y A SG 11201707892YA SG 11201707892Y A SG11201707892Y A SG 11201707892YA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- treating inflammatory
- immunological disorders
- immunological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/670,641 US9999635B2 (en) | 2007-01-16 | 2015-03-27 | Methods and compositions for treating inflammatory disorders |
| PCT/US2016/024453 WO2016160668A1 (fr) | 2015-03-27 | 2016-03-28 | Méthodes et compositions pour le traitement de troubles inflammatoires et immunologiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201707892YA true SG11201707892YA (en) | 2017-10-30 |
Family
ID=57006380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201707892YA SG11201707892YA (en) | 2015-03-27 | 2016-03-28 | Methods and compositions for treating inflammatory and immunological disorders |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10617716B2 (fr) |
| EP (1) | EP3273973A4 (fr) |
| JP (1) | JP2018509460A (fr) |
| KR (1) | KR20180012745A (fr) |
| CN (1) | CN107847520A (fr) |
| AU (1) | AU2016243554A1 (fr) |
| CA (1) | CA2980966A1 (fr) |
| HK (1) | HK1250337A1 (fr) |
| IL (1) | IL254671A0 (fr) |
| MX (1) | MX2017012433A (fr) |
| SG (1) | SG11201707892YA (fr) |
| WO (1) | WO2016160668A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
| US10617716B2 (en) | 2014-12-16 | 2020-04-14 | Urgo Us, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
| CA2970804C (fr) | 2014-12-16 | 2023-01-31 | Realm Therapeutics, Inc. | Formulations d'acide hypochloreux et methodes de traitement des maladies de peau |
| US11324734B2 (en) | 2015-04-01 | 2022-05-10 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
| ZA201707084B (en) * | 2016-10-21 | 2018-11-28 | Ultrapure Hocl Pty Ltd | Hypochlorous acid |
| EP3626339A4 (fr) * | 2017-06-17 | 2021-12-15 | Acenet Inc. | Catalyseur de génération de radicaux, procédé de production de radicaux, procédé de production de produit de réaction d'oxydation, médicament, et médecine de l'agriculture et du bétail |
| US11090236B2 (en) * | 2018-05-02 | 2021-08-17 | Ocusoft, Inc. | Hypochlorous acid-based eyelid cleansers |
| US20210283197A1 (en) * | 2018-07-17 | 2021-09-16 | Ferring B.V. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
| US20230181628A1 (en) * | 2020-05-21 | 2023-06-15 | Osaka University | Epithelial cancer therapeutic agent |
| GB2599795A (en) * | 2020-09-15 | 2022-04-13 | Facerestoration Ltd | Lavage techniques and virucidal compositions comprising hypochlorous solutions |
| US20220202853A1 (en) * | 2020-12-28 | 2022-06-30 | Briotech, Inc. | Hypohalous acids for treating inflammatory diseases and inhibiting growth of malignancies |
| GB202110146D0 (en) * | 2021-07-14 | 2021-08-25 | Hypo Stream Ltd | Treatment of respiratory conditions |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10236961A (ja) * | 1997-02-25 | 1998-09-08 | Nobel Igaku Kenkyusho:Kk | 電解酸性水を用いた眼科用剤 |
| GB2355190B (en) | 1999-08-23 | 2004-07-28 | Sterilox Medical | Improvements in or relating to sterilising preparations |
| US6333054B1 (en) | 1999-10-21 | 2001-12-25 | Amuchina S.P.A. | Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| US20030185704A1 (en) * | 2000-01-12 | 2003-10-02 | Suzanne Bernard | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| US9168318B2 (en) * | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
| AU2006226750B2 (en) * | 2005-03-23 | 2012-07-19 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
| CA2637178C (fr) * | 2006-01-20 | 2018-09-04 | Oculus Innovative Sciences, Inc. | Methodes de prevention ou de traitement de la sinusite au moyen d'une solution d'eau a potentiel d'oxydo-reduction |
| CN101405013A (zh) | 2006-01-20 | 2009-04-08 | 奥古露丝创新科学公司 | 使用氧化还原电位水溶液治疗或预防腹膜炎的方法 |
| WO2007124591A1 (fr) | 2006-05-03 | 2007-11-08 | University Of Manitoba | Marqueurs microbiens de colopathie fonctionnelle |
| JP4372121B2 (ja) * | 2006-06-24 | 2009-11-25 | 有限会社上川製作所 | 家畜腸内の大腸菌減少剤、家畜体内の脂肪減少剤及び家畜の飼育方法 |
| US8877257B2 (en) | 2007-01-16 | 2014-11-04 | Puricore, Inc. | Methods and compositions for treating conditions associated with infection and/or inflammation |
| US9999635B2 (en) | 2007-01-16 | 2018-06-19 | Realm Therapeutics, Inc. | Methods and compositions for treating inflammatory disorders |
| CN105213299A (zh) * | 2007-07-26 | 2016-01-06 | Azad药物股份公司 | 含有电化学活化的次氯酸盐溶液的药物制剂 |
| WO2009145982A1 (fr) | 2008-04-01 | 2009-12-03 | Antipodean Pharmaceuticals, Inc. | Compositions et procédés pour le soin de la peau |
| JP2011116730A (ja) * | 2009-12-04 | 2011-06-16 | Yasuharu Shima | 呼吸器系疾患の予防と治療方法 |
| WO2011074619A1 (fr) * | 2009-12-16 | 2011-06-23 | 日本カーリット株式会社 | Matière colorante absorbant dans le proche infrarouge et composition absorbant dans le proche infrarouge |
| ES2741480T3 (es) | 2011-03-18 | 2020-02-11 | Urgo Us Inc | Soluciones estabilizadas de ácido hipohaloso |
| US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
| US10617716B2 (en) | 2014-12-16 | 2020-04-14 | Urgo Us, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
-
2015
- 2015-12-16 US US15/535,555 patent/US10617716B2/en active Active
-
2016
- 2016-03-28 WO PCT/US2016/024453 patent/WO2016160668A1/fr active Application Filing
- 2016-03-28 AU AU2016243554A patent/AU2016243554A1/en not_active Abandoned
- 2016-03-28 SG SG11201707892YA patent/SG11201707892YA/en unknown
- 2016-03-28 US US15/562,144 patent/US20180078578A1/en not_active Abandoned
- 2016-03-28 KR KR1020177031240A patent/KR20180012745A/ko unknown
- 2016-03-28 MX MX2017012433A patent/MX2017012433A/es unknown
- 2016-03-28 CA CA2980966A patent/CA2980966A1/fr not_active Abandoned
- 2016-03-28 EP EP16773906.9A patent/EP3273973A4/fr not_active Withdrawn
- 2016-03-28 JP JP2017550556A patent/JP2018509460A/ja active Pending
- 2016-03-28 CN CN201680030744.5A patent/CN107847520A/zh active Pending
-
2017
- 2017-09-25 IL IL254671A patent/IL254671A0/en unknown
-
2018
- 2018-07-27 HK HK18109756.5A patent/HK1250337A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180078578A1 (en) | 2018-03-22 |
| JP2018509460A (ja) | 2018-04-05 |
| EP3273973A4 (fr) | 2018-12-05 |
| EP3273973A1 (fr) | 2018-01-31 |
| US20170360832A1 (en) | 2017-12-21 |
| HK1250337A1 (zh) | 2018-12-14 |
| KR20180012745A (ko) | 2018-02-06 |
| AU2016243554A1 (en) | 2017-10-19 |
| US10617716B2 (en) | 2020-04-14 |
| WO2016160668A1 (fr) | 2016-10-06 |
| MX2017012433A (es) | 2018-03-26 |
| CA2980966A1 (fr) | 2016-10-06 |
| CN107847520A (zh) | 2018-03-27 |
| IL254671A0 (en) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250337A1 (zh) | 治療炎性病症和免疫疾病的方法和組合物 | |
| IL251721A0 (en) | Preparations and methods for the treatment of diseases of the central nervous system | |
| RS60642B1 (sr) | Kompozicije i postupci za lečenje poremećaja cns-a | |
| SI3224269T1 (sl) | Sestavki in metode za zdravljenje CNS motenj | |
| HUE054092T2 (hu) | Központi idegrendszeri zavarok kezelésére szolgáló kompozíciók és eljárások | |
| IL248837A0 (en) | Methods and preparations for the treatment of autoimmune and inflammatory conditions | |
| IL250715A0 (en) | Preparations and methods for the treatment of cultural disorders | |
| EP3126004A4 (fr) | Méthodes et compositions pour le traitement de troubles inflammatoires | |
| IL270304A (en) | Methods and preparations for the treatment of inflammatory disorders in the digestive system | |
| EP3280420A4 (fr) | Compositions et méthodes permettant de traiter des troubles du snc | |
| SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
| EP3262065A4 (fr) | Procédés et compositions de traitement des dystroglycanopathies | |
| HK1247123A1 (zh) | 治療copd和其它炎症性病況的組合物和方法 | |
| PT3420084T (pt) | Nova abordagem para tratamento de disfunções inflamatórias | |
| GB201521543D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513993D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513345D0 (en) | Methods for the treatment of Inflammatory disorders | |
| GB201507113D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201506419D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201506229D0 (en) | Methods For the Treatment Of Inflammatory Disorders |